BioSpace News Archive

Tegra Medical, a leading contract manufacturer of medical devices and a member of SFS, which is headquartered in Heerbrugg Switzerland, today announced it is expanding operations into Europe and Asia

The American Academy of Family Physicians is pleased to announce that Shannon M. Scott has been named chief strategy officer, and on Jan. 1, 2021, she will also assume the role of deputy executive vice president (DEVP).

Saama Technologies, Inc., the #1 AI clinical analytics platform company, announced the launch of the new Active Safety Analytics for Pharma product.

The Bristol Myers Squibb–Pfizer Alliance, with the support of leading advocacy organizations and medical societies, announces the launch of the No Time to Wait campaign

Lygos, Inc., a vertically integrated provider of safe and sustainable specialty ingredients, today announced the launch of Lygos CBx, a Lygos company and new website focused on delivering a wide range of high-quality, pure and sustainable non-plant-based cannabinoids

Acadia Pharmaceuticals to Present New Scientific Data on Pimavanserin in Neurodegenerative Diseases at the 13 th Clinical Trials on Alzheimer’s Disease (CTAD) Conference

TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that it has expanded its engagement with one of its Contract Manufacturing Organization (CMOs), Experic, LLC, with an agreement to install a Thin Film Freezing processing line and its associ

Greenphire, the global leader in financial lifecycle management for clinical trials, says patient enrollment for global clinical trials has returned to pre-COVID levels.

Data highlight the importance of early intervention with fast-acting E-selectin inhibitors to disrupt the underlying inflammatory mechanisms driving acute vaso-occlusive crisis (VOC) - Abstracts for two of GlycoMimetics’ wholly-owned product candidates, rivipansel and GMI-1687, accepted for poster and oral presentations ROCKVILLE, Md.--( BUSINESS WIRE )-- GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that new post hoc analyses of the

Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology based therapies for prevalent inflammatory conditions, announced today that the Company will present at the 2020 MedTech Innovation Forum hosted by Roth Capital Partners on Wednesday, October 28, 2020.